Human CacyBP has been shown to have roles in p53-induced degradation of non-phosphorylated human β-catenin [64], cytoskeleton organization, dephosphorylation of ERK1/2, cell proliferation and cancer development [65]. This evidence concerns the gene MAPK3 and cancer.